Lulibor Cream contains Luliconazole 1% w/w, a topical antifungal agent indicated for the treatment of superficial fungal infections of the skin, including tinea corporis, tinea cruris, and tinea pedis. Luliconazole belongs to the imidazole class of antifungals and exerts its effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to increased membrane permeability and ultimately fungal cell death. The cream formulation allows for targeted application to affected areas, promoting rapid relief of symptoms such as itching, redness, and scaling. Lulibor Cream is typically applied once daily to the clean, dry affected area and surrounding skin for a duration prescribed by the healthcare provider, generally ranging from 1 to 2 weeks depending on the infection type and severity. It is well tolerated with minimal adverse effects; however, patients may occasionally experience mild local irritation, burning, or erythema at the application site. Lulibor Cream should not be used in individuals with known hypersensitivity to luliconazole or any excipients in the formulation. It is intended for external use only and should be kept out of reach of children. Consultation with a healthcare professional is recommended before initiating therapy to ensure appropriate diagnosis and treatment.